Dentsply Sirona Receives Notice of Filing Delinquency from Nasdaq
15 Agosto 2022 - 5:30PM
DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq:
XRAY) today announced that, as expected, it received written
notification from The NASDAQ Stock Market (“Nasdaq”) on August 12,
2022 that the Company remains out of compliance with the Nasdaq
Listing Rules because the Company has not yet filed its Quarterly
Reports on Form 10-Q for the periods ended March 31, 2022 and June
30, 2022 (individually the “First Quarter 10-Q” and “Second Quarter
10-Q,” respectively, and together, the “Quarterly Reports”). Nasdaq
Listing Rule 5250(c)(1) requires Nasdaq-listed companies to timely
file all periodic reports.
The Company previously received written
notification from Nasdaq on May 12, 2022, that it was not in
compliance with Nasdaq Listing Rules since the Company had not
timely filed its First Quarter 10-Q. In response to the
notification and pursuant to the Nasdaq Listing Rules, the Company
submitted a plan to Nasdaq to regain compliance and it targeted
filing the First Quarter 10-Q by August 14, 2022. Nasdaq granted
the Company an extension of time through August 14, 2022, in which
to regain compliance. As stated in the Company’s press release
dated August 4, 2022, the Company notified Nasdaq that it no longer
expected that it would be able to file First Quarter 10-Q or the
Second Quarter 10-Q by August 14, 2022. On August 13, 2022, the
Company submitted an updated compliance plan to Nasdaq with a
request to Nasdaq for additional time to demonstrate compliance
with the listing rules. If approved, Nasdaq could grant a continued
exception to allow the Company to regain compliance with all
delinquent filings for up to 180 days from the filing deadline of
the First Quarter 10-Q, which is November 7, 2022.
Neither this notice nor the May 12, 2022, notice from Nasdaq has
an immediate effect on the listing of the Company’s common stock on
the Nasdaq Global Market. As previously reported in the Company’s
Notification of Late Filing on Form 12b-25 filed with the SEC on
August 9, 2022, the Company was unable to file the Quarterly
Reports within the prescribed periods because the Audit and Finance
Committee of the Company’s Board of Directors is conducting an
internal investigation regarding certain financial reporting
matters and the Company is also in the process of evaluating
certain other accounting practices.
The Company is working to finalize its financial statements for
the Quarterly Reports and review of internal controls and
procedures, including the evaluation of any deficiencies in
internal control over financial reporting, as soon as
practicable.
About Dentsply SironaDentsply
Sirona is the world’s largest manufacturer of professional dental
products and technologies, with over a century of innovation and
service to the dental industry and patients worldwide. Dentsply
Sirona develops, manufactures, and markets a comprehensive
solutions offering including dental and oral health products as
well as other consumable medical devices under a strong portfolio
of world class brands. Dentsply Sirona’s products provide
innovative, high-quality and effective solutions to advance patient
care and deliver better and safer dental care. Dentsply Sirona’s
headquarters is located in Charlotte, North Carolina. The Company’s
shares are listed in the United States on Nasdaq under the symbol
XRAY. Visit www.dentsplysirona.com for more information about
Dentsply Sirona and its products.
Contact
Information:Investors:Andrea DaleyVice President, Investor
Relations+1-704-805-1293InvestorRelations@dentsplysirona.com
Forward-Looking Statements and
Associated Risks
All statements in this press release that do not directly and
exclusively relate to historical facts constitute “forward-looking
statements.” These statements, including statements regarding the
ongoing internal investigation and exceptions to the Nasdaq listing
rules, represent current expectations and beliefs, and no assurance
can be given that the results described in such statements will be
achieved. Such statements are subject to numerous assumptions,
risks, uncertainties and other factors that could cause actual
results to differ materially from those described in such
statements, many of which are outside of our control. Furthermore,
many of these risks and uncertainties are currently amplified by
and may continue to be amplified by or may, in the future, be
amplified by, the novel coronavirus (“COVID-19”) pandemic and the
impact of varying private and governmental responses that affect
our customers, employees, vendors and the economies and communities
where they operate. For a written description of these factors, see
the section titled “Risk Factors” in Dentsply Sirona’s Annual
Report on Form 10-K for the fiscal year ended December 31, 2021 and
any updating information in subsequent SEC filings. No assurance
can be given that any expectation, belief, goal or plan set forth
in any forward-looking statement can or will be achieved, and
readers are cautioned not to place undue reliance on such
statements which speak only as of the date they are made. We do not
undertake any obligation to update or release any revisions to any
forward-looking statement or to report any events or circumstances
after the date of this press release or to reflect the occurrence
of unanticipated events.
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024